{"transactions":[{"id":4627069,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-25T20:51:22.000Z","date":"2026-09-23","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":10000,"derivative":{"exercise_price":10.99,"expiration_date":"2036-09-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-26-063606","document":"wk-form4_1790369479.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586788/000162828026063606/wk-form4_1790369479.xml","form_type":"4"}},{"id":4620073,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-16T22:44:56.000Z","date":"2026-09-15","kind":"exercise","planned":false,"acquired":false,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":150120,"derivative":{"exercise_price":1.01,"expiration_date":"2030-03-10","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001193125-26-393353","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526393353/ownership.xml","form_type":"4"}},{"id":4620072,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-16T22:44:56.000Z","date":"2026-09-15","kind":"exercise","planned":false,"acquired":true,"shares":36000,"price":1.01,"value":36360.0,"ownership":{"direct":true},"balance_after":262064,"source":{"system":"sec-edgar","filing":"0001193125-26-393353","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526393353/ownership.xml","form_type":"4"}},{"id":683660,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-18T22:56:47.000Z","date":"2026-08-17","kind":"exercise","planned":true,"acquired":false,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this option vest in 48 equal monthly installments following December 29, 2022, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":91586,"derivative":{"exercise_price":13.5,"expiration_date":"2032-12-28","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001193125-26-355841","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526355841/ownership.xml","form_type":"4"}},{"id":683659,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-18T22:56:47.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":11888,"price":79.842,"value":949161.696,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.53 to $80.02, inclusive."}],"balance_after":226064,"source":{"system":"sec-edgar","filing":"0001193125-26-355841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526355841/ownership.xml","form_type":"4"}},{"id":683658,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-18T22:56:47.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":12712,"price":79.1952,"value":1006729.3824,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.53 to $79.52, inclusive."}],"balance_after":237952,"source":{"system":"sec-edgar","filing":"0001193125-26-355841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526355841/ownership.xml","form_type":"4"}},{"id":683657,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-18T22:56:47.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":8400,"price":78.1061,"value":656091.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.50 to $78.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4."}],"balance_after":250664,"source":{"system":"sec-edgar","filing":"0001193125-26-355841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526355841/ownership.xml","form_type":"4"}},{"id":683656,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-18T22:56:47.000Z","date":"2026-08-17","kind":"exercise","planned":true,"acquired":true,"shares":33000,"price":13.5,"value":445500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026."}],"balance_after":259064,"source":{"system":"sec-edgar","filing":"0001193125-26-355841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526355841/ownership.xml","form_type":"4"}},{"id":709826,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-14T22:32:13.000Z","date":"2026-07-13","kind":"exercise","planned":true,"acquired":false,"shares":7416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this option vest in 48 equal monthly installments following December 29, 2022, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":124586,"derivative":{"exercise_price":13.5,"expiration_date":"2032-12-28","underlying":"Common Stock","underlying_shares":7416},"source":{"system":"sec-edgar","filing":"0001193125-26-303535","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526303535/ownership.xml","form_type":"4"}},{"id":709825,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-14T22:32:13.000Z","date":"2026-07-13","kind":"exercise","planned":true,"acquired":false,"shares":25584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":15791,"derivative":{"exercise_price":9.86,"expiration_date":"2031-09-13","underlying":"Common Stock","underlying_shares":25584},"source":{"system":"sec-edgar","filing":"0001193125-26-303535","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526303535/ownership.xml","form_type":"4"}},{"id":709824,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-14T22:32:13.000Z","date":"2026-07-13","kind":"sale","planned":true,"acquired":false,"shares":6400,"price":76.052,"value":486732.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.83 to $76.29, inclusive."}],"balance_after":226064,"source":{"system":"sec-edgar","filing":"0001193125-26-303535","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526303535/ownership.xml","form_type":"4"}},{"id":709823,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-14T22:32:13.000Z","date":"2026-07-13","kind":"sale","planned":true,"acquired":false,"shares":16896,"price":74.9469,"value":1266302.8224,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.62 to $75.50, inclusive."}],"balance_after":232464,"source":{"system":"sec-edgar","filing":"0001193125-26-303535","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526303535/ownership.xml","form_type":"4"}},{"id":709822,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-14T22:32:13.000Z","date":"2026-07-13","kind":"sale","planned":true,"acquired":false,"shares":9704,"price":74.2729,"value":720744.2216,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.62 to $74.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4."}],"balance_after":249360,"source":{"system":"sec-edgar","filing":"0001193125-26-303535","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526303535/ownership.xml","form_type":"4"}},{"id":709821,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-14T22:32:13.000Z","date":"2026-07-13","kind":"exercise","planned":true,"acquired":true,"shares":7416,"price":13.5,"value":100116.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026."}],"balance_after":259064,"source":{"system":"sec-edgar","filing":"0001193125-26-303535","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526303535/ownership.xml","form_type":"4"}},{"id":709820,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-14T22:32:13.000Z","date":"2026-07-13","kind":"exercise","planned":true,"acquired":true,"shares":25584,"price":9.86,"value":252258.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026."}],"balance_after":251648,"source":{"system":"sec-edgar","filing":"0001193125-26-303535","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526303535/ownership.xml","form_type":"4"}},{"id":729213,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T21:16:08.000Z","date":"2026-06-18","kind":"exercise","planned":true,"acquired":false,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":41375,"derivative":{"exercise_price":9.86,"expiration_date":"2031-09-13","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001193125-26-279779","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526279779/ownership.xml","form_type":"4"}},{"id":729212,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-23T21:16:08.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":1551,"price":71.6126,"value":111071.1426,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.36 to $71.85, inclusive."}],"balance_after":226064,"source":{"system":"sec-edgar","filing":"0001193125-26-279779","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526279779/ownership.xml","form_type":"4"}},{"id":729211,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-23T21:16:08.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":9522,"price":70.7,"value":673205.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.36 to $71.35, inclusive."}],"balance_after":227615,"source":{"system":"sec-edgar","filing":"0001193125-26-279779","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526279779/ownership.xml","form_type":"4"}},{"id":729210,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-23T21:16:08.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":22927,"price":69.9184,"value":1603019.1568,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.35 to $70.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4."}],"balance_after":237137,"source":{"system":"sec-edgar","filing":"0001193125-26-279779","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526279779/ownership.xml","form_type":"4"}},{"id":729209,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-23T21:16:08.000Z","date":"2026-06-18","kind":"exercise","planned":true,"acquired":true,"shares":34000,"price":9.86,"value":335240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026."}],"balance_after":260064,"source":{"system":"sec-edgar","filing":"0001193125-26-279779","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526279779/ownership.xml","form_type":"4"}},{"id":747496,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T21:45:45.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award made pursuant to Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":115000,"derivative":{"exercise_price":0.178,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001728117-26-000047","document":"wk-form4_1780695943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586788/000172811726000047/wk-form4_1780695943.xml","form_type":"4"}},{"id":901174,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-18T02:03:45.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":13264,"price":62.86,"value":833775.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I. This sale is a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":226064,"source":{"system":"sec-edgar","filing":"0001193125-26-055623","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526055623/ownership.xml","form_type":"4"}},{"id":910065,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-12T00:12:49.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":82800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest in 48 equal monthly installments commencing on March 10, 2026, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":82800,"derivative":{"exercise_price":74.75,"expiration_date":"2036-02-09","underlying":"Common Stock","underlying_shares":82800},"source":{"system":"sec-edgar","filing":"0001193125-26-047146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526047146/ownership.xml","form_type":"4"}},{"id":910064,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-12T00:12:49.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":55200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"), each representing a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest annually in four 25% installments commencing on February 15, 2027, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":239328,"source":{"system":"sec-edgar","filing":"0001193125-26-047146","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526047146/ownership.xml","form_type":"4"}},{"id":962088,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-19T23:16:36.000Z","date":"2025-12-19","kind":"exercise","planned":false,"acquired":false,"shares":12300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":186120,"derivative":{"exercise_price":1.01,"expiration_date":"2030-03-10","underlying":"Common Stock","underlying_shares":12300},"source":{"system":"sec-edgar","filing":"0001193125-25-327173","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312525327173/ownership.xml","form_type":"4"}},{"id":962087,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-19T23:16:36.000Z","date":"2025-12-19","kind":"exercise","planned":false,"acquired":true,"shares":12300,"price":1.01,"value":12423.0,"ownership":{"direct":true},"balance_after":184128,"source":{"system":"sec-edgar","filing":"0001193125-25-327173","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312525327173/ownership.xml","form_type":"4"}},{"id":969595,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-15T22:49:00.000Z","date":"2025-12-11","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":75375,"derivative":{"exercise_price":9.86,"expiration_date":"2031-09-13","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001193125-25-319503","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312525319503/ownership.xml","form_type":"4"}},{"id":969594,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-15T22:49:00.000Z","date":"2025-12-11","kind":"sale","planned":true,"acquired":false,"shares":16888,"price":93.6493,"value":1581549.3784,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.46 to $94.24, inclusive."}],"balance_after":171828,"source":{"system":"sec-edgar","filing":"0001193125-25-319503","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312525319503/ownership.xml","form_type":"4"}},{"id":969593,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-15T22:49:00.000Z","date":"2025-12-11","kind":"sale","planned":true,"acquired":false,"shares":16356,"price":92.9566,"value":1520398.1496,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.46 to $93.44, inclusive."}],"balance_after":188716,"source":{"system":"sec-edgar","filing":"0001193125-25-319503","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312525319503/ownership.xml","form_type":"4"}},{"id":969592,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-15T22:49:00.000Z","date":"2025-12-11","kind":"sale","planned":true,"acquired":false,"shares":4337,"price":92.2112,"value":399919.9744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.46 to $92.43, inclusive."}],"balance_after":205072,"source":{"system":"sec-edgar","filing":"0001193125-25-319503","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312525319503/ownership.xml","form_type":"4"}},{"id":969591,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-15T22:49:00.000Z","date":"2025-12-11","kind":"sale","planned":true,"acquired":false,"shares":2419,"price":90.973,"value":220063.687,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.40 to $91.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) to this Form 4."}],"balance_after":209409,"source":{"system":"sec-edgar","filing":"0001193125-25-319503","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312525319503/ownership.xml","form_type":"4"}},{"id":969590,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-15T22:49:00.000Z","date":"2025-12-11","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":9.86,"value":394400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025."}],"balance_after":211828,"source":{"system":"sec-edgar","filing":"0001193125-25-319503","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312525319503/ownership.xml","form_type":"4"}},{"id":1042945,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-11T22:00:09.000Z","date":"2025-09-09","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":198420,"derivative":{"exercise_price":1.01,"expiration_date":"2030-03-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001586788-25-000004","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000158678825000004/ownership.xml","form_type":"4"}},{"id":1042944,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-11T22:00:09.000Z","date":"2025-09-09","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":1.01,"value":10100.0,"ownership":{"direct":true},"balance_after":171828,"source":{"system":"sec-edgar","filing":"0001586788-25-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000158678825000004/ownership.xml","form_type":"4"}},{"id":1088628,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-11T20:48:28.000Z","date":"2025-07-09","kind":"exercise","planned":true,"acquired":false,"shares":34800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":115375,"derivative":{"exercise_price":9.86,"expiration_date":"2031-09-13","underlying":"Common Stock","underlying_shares":34800},"source":{"system":"sec-edgar","filing":"0000950170-25-095338","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025095338/ownership.xml","form_type":"4"}},{"id":1088627,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-07-11T20:48:28.000Z","date":"2025-07-09","kind":"sale","planned":true,"acquired":false,"shares":3593,"price":56.1995,"value":201924.8035,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.00 to $56.33, inclusive."}],"balance_after":161828,"source":{"system":"sec-edgar","filing":"0000950170-25-095338","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025095338/ownership.xml","form_type":"4"}},{"id":1088626,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-07-11T20:48:28.000Z","date":"2025-07-09","kind":"sale","planned":true,"acquired":false,"shares":31207,"price":55.2312,"value":1723600.0584,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":165421,"source":{"system":"sec-edgar","filing":"0000950170-25-095338","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025095338/ownership.xml","form_type":"4"}},{"id":1088625,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-07-11T20:48:28.000Z","date":"2025-07-09","kind":"exercise","planned":true,"acquired":true,"shares":34800,"price":9.86,"value":343128.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025."}],"balance_after":196628,"source":{"system":"sec-edgar","filing":"0000950170-25-095338","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025095338/ownership.xml","form_type":"4"}},{"id":1090691,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-09T00:19:12.000Z","date":"2025-07-03","kind":"exercise","planned":true,"acquired":false,"shares":5200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":150175,"derivative":{"exercise_price":9.86,"expiration_date":"2031-09-13","underlying":"Common Stock","underlying_shares":5200},"source":{"system":"sec-edgar","filing":"0000950170-25-094695","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025094695/ownership.xml","form_type":"4"}},{"id":1090690,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-07-09T00:19:12.000Z","date":"2025-07-03","kind":"sale","planned":true,"acquired":false,"shares":5200,"price":55.0874,"value":286454.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":161828,"source":{"system":"sec-edgar","filing":"0000950170-25-094695","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025094695/ownership.xml","form_type":"4"}},{"id":1090689,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-07-09T00:19:12.000Z","date":"2025-07-03","kind":"exercise","planned":true,"acquired":true,"shares":5200,"price":9.86,"value":51272.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025."}],"balance_after":167028,"source":{"system":"sec-edgar","filing":"0000950170-25-094695","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025094695/ownership.xml","form_type":"4"}},{"id":1100819,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-26T20:37:32.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award made pursuant to Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":115000,"derivative":{"exercise_price":1.36,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001728117-25-000055","document":"wk-form4_1750970243.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586788/000172811725000055/wk-form4_1750970243.xml","form_type":"4"}},{"id":1175699,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-09T00:22:20.000Z","date":"2025-04-07","kind":"exercise","planned":false,"acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":208420,"derivative":{"exercise_price":1.01,"expiration_date":"2030-03-10","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0000950170-25-052289","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025052289/ownership.xml","form_type":"4"}},{"id":1175698,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-09T00:22:20.000Z","date":"2025-04-07","kind":"exercise","planned":false,"acquired":true,"shares":7000,"price":1.01,"value":7070.0,"ownership":{"direct":true},"balance_after":161828,"source":{"system":"sec-edgar","filing":"0000950170-25-052289","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025052289/ownership.xml","form_type":"4"}},{"id":1255981,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-21T00:27:58.000Z","date":"2025-02-18","kind":"sale","planned":false,"acquired":false,"shares":5574,"price":54.58,"value":304228.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units granted on January 10, 2024 and previously reported in Table I. This sale is a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":154828,"source":{"system":"sec-edgar","filing":"0000950170-25-024471","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025024471/ownership.xml","form_type":"4"}},{"id":1271845,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-12T23:35:51.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":117505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest in 48 equal monthly installments commencing on March 10, 2025, subject to the Reporting Person's continuted service on each such vesting date."}],"balance_after":117505,"derivative":{"exercise_price":54.71,"expiration_date":"2035-02-09","underlying":"Common Stock","underlying_shares":117505},"source":{"system":"sec-edgar","filing":"0000950170-25-019089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025019089/ownership.xml","form_type":"4"}},{"id":1271844,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-12T23:35:51.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":78337,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"), each representing a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest annually in four 25% installments commencing on February 15, 2026, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":160402,"source":{"system":"sec-edgar","filing":"0000950170-25-019089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025019089/ownership.xml","form_type":"4"}},{"id":1318762,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-03T00:13:23.000Z","date":"2024-12-31","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":215420,"derivative":{"exercise_price":1.01,"expiration_date":"2030-03-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000950170-25-000617","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025000617/ownership.xml","form_type":"4"}},{"id":1318761,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-03T00:13:23.000Z","date":"2024-12-30","kind":"exercise","planned":true,"acquired":false,"shares":13012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 2, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":155375,"derivative":{"exercise_price":9.86,"expiration_date":"2031-09-13","underlying":"Common Stock","underlying_shares":13012},"source":{"system":"sec-edgar","filing":"0000950170-25-000617","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025000617/ownership.xml","form_type":"4"}},{"id":1318760,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-03T00:13:23.000Z","date":"2024-12-31","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":1.01,"value":10100.0,"ownership":{"direct":true},"balance_after":82065,"source":{"system":"sec-edgar","filing":"0000950170-25-000617","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025000617/ownership.xml","form_type":"4"}},{"id":1318759,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-03T00:13:23.000Z","date":"2024-12-30","kind":"sale","planned":true,"acquired":false,"shares":1900,"price":62.4107,"value":118580.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 2, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.31 to $62.58, inclusive."}],"balance_after":72065,"source":{"system":"sec-edgar","filing":"0000950170-25-000617","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025000617/ownership.xml","form_type":"4"}},{"id":1318758,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-03T00:13:23.000Z","date":"2024-12-30","kind":"sale","planned":true,"acquired":false,"shares":11112,"price":61.868,"value":687477.216,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 2, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.29 to $62.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":73965,"source":{"system":"sec-edgar","filing":"0000950170-25-000617","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025000617/ownership.xml","form_type":"4"}},{"id":1318757,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-03T00:13:23.000Z","date":"2024-12-30","kind":"exercise","planned":true,"acquired":true,"shares":13012,"price":9.86,"value":128298.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 2, 2024."}],"balance_after":85077,"source":{"system":"sec-edgar","filing":"0000950170-25-000617","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025000617/ownership.xml","form_type":"4"}},{"id":1321756,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-26T22:18:36.000Z","date":"2024-12-23","kind":"exercise","planned":true,"acquired":false,"shares":19820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 2, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":41830,"derivative":{"exercise_price":2.65,"expiration_date":"2030-10-22","underlying":"Common Stock","underlying_shares":19820},"source":{"system":"sec-edgar","filing":"0000950170-24-140502","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017024140502/ownership.xml","form_type":"4"}},{"id":1321755,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-12-26T22:18:36.000Z","date":"2024-12-23","kind":"sale","planned":true,"acquired":false,"shares":4212,"price":63.8017,"value":268732.7604,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 2, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.695 to $63.86, inclusive."}],"balance_after":72065,"source":{"system":"sec-edgar","filing":"0000950170-24-140502","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017024140502/ownership.xml","form_type":"4"}},{"id":1321754,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-12-26T22:18:36.000Z","date":"2024-12-23","kind":"sale","planned":true,"acquired":false,"shares":12194,"price":63.1185,"value":769666.989,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 2, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.66 to $63.655, inclusive."}],"balance_after":76277,"source":{"system":"sec-edgar","filing":"0000950170-24-140502","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017024140502/ownership.xml","form_type":"4"}},{"id":1321753,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-12-26T22:18:36.000Z","date":"2024-12-23","kind":"sale","planned":true,"acquired":false,"shares":3414,"price":62.3777,"value":212957.4678,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 2, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.66 to $62.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4."}],"balance_after":88471,"source":{"system":"sec-edgar","filing":"0000950170-24-140502","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017024140502/ownership.xml","form_type":"4"}},{"id":1321752,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-12-26T22:18:36.000Z","date":"2024-12-23","kind":"exercise","planned":true,"acquired":true,"shares":19820,"price":2.65,"value":52523.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 2, 2024."}],"balance_after":91885,"source":{"system":"sec-edgar","filing":"0000950170-24-140502","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017024140502/ownership.xml","form_type":"4"}},{"id":1326840,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-19T00:41:34.000Z","date":"2024-12-16","kind":"exercise","planned":true,"acquired":false,"shares":12791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 2, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":225420,"derivative":{"exercise_price":1.01,"expiration_date":"2030-03-10","underlying":"Common Stock","underlying_shares":12791},"source":{"system":"sec-edgar","filing":"0000950170-24-138086","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017024138086/ownership.xml","form_type":"4"}},{"id":1326839,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-12-19T00:41:34.000Z","date":"2024-12-16","kind":"sale","planned":true,"acquired":false,"shares":500,"price":67.198,"value":33599.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 2, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.04 to $67.54, inclusive."}],"balance_after":72065,"source":{"system":"sec-edgar","filing":"0000950170-24-138086","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017024138086/ownership.xml","form_type":"4"}},{"id":1326838,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-12-19T00:41:34.000Z","date":"2024-12-16","kind":"sale","planned":true,"acquired":false,"shares":6305,"price":66.3539,"value":418361.3395,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 2, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.04 to $67.01, inclusive."}],"balance_after":72565,"source":{"system":"sec-edgar","filing":"0000950170-24-138086","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017024138086/ownership.xml","form_type":"4"}},{"id":1326837,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-12-19T00:41:34.000Z","date":"2024-12-16","kind":"sale","planned":true,"acquired":false,"shares":5767,"price":65.5789,"value":378193.5163,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 2, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.04 to $66.03, inclusive."}],"balance_after":78870,"source":{"system":"sec-edgar","filing":"0000950170-24-138086","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017024138086/ownership.xml","form_type":"4"}},{"id":1326836,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-12-19T00:41:34.000Z","date":"2024-12-16","kind":"sale","planned":true,"acquired":false,"shares":219,"price":64.6586,"value":14160.2334,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 2, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.04 to $65.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4."}],"balance_after":84637,"source":{"system":"sec-edgar","filing":"0000950170-24-138086","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017024138086/ownership.xml","form_type":"4"}},{"id":1326835,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-12-19T00:41:34.000Z","date":"2024-12-16","kind":"exercise","planned":true,"acquired":true,"shares":12791,"price":1.01,"value":12918.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 2, 2024."}],"balance_after":84856,"source":{"system":"sec-edgar","filing":"0000950170-24-138086","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017024138086/ownership.xml","form_type":"4"}},{"id":1456975,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-10T20:15:02.000Z","date":"2024-07-08","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":238211,"derivative":{"exercise_price":1.01,"expiration_date":"2030-03-10","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000950170-24-082693","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017024082693/ownership.xml","form_type":"4"}},{"id":1456974,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-07-10T20:15:02.000Z","date":"2024-07-08","kind":"exercise","planned":false,"acquired":true,"shares":3000,"price":1.01,"value":3030.0,"ownership":{"direct":true},"balance_after":72065,"source":{"system":"sec-edgar","filing":"0000950170-24-082693","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017024082693/ownership.xml","form_type":"4"}},{"id":1488058,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (Right to Buy)","published_at":"2024-06-07T01:59:04.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award made pursuant to Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":115000,"derivative":{"exercise_price":0.6,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001728117-24-000067","document":"wk-form4_1717725537.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586788/000172811724000067/wk-form4_1717725537.xml","form_type":"4"}},{"id":1607430,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-02T00:42:59.000Z","date":"2024-01-10","kind":"grant","planned":false,"acquired":true,"shares":99550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option shall vest and become exercisable on January 10, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":99550,"derivative":{"exercise_price":63.9,"expiration_date":"2034-01-09","underlying":"Common Stock","underlying_shares":99550},"source":{"system":"sec-edgar","filing":"0000950170-24-024199","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017024024199/ownership.xml","form_type":"4"}},{"id":1607429,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-02T00:42:59.000Z","date":"2024-01-10","kind":"grant","planned":false,"acquired":true,"shares":66365,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":69065,"source":{"system":"sec-edgar","filing":"0000950170-24-024199","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017024024199/ownership.xml","form_type":"4"}},{"id":1692998,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-03T21:05:18.000Z","date":"2023-12-29","kind":"exercise","planned":false,"acquired":false,"shares":2700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option vested on February 25, 2021, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to the\nReporting Person's continued service on each such vesting date."}],"balance_after":241211,"derivative":{"exercise_price":1.01,"expiration_date":"2030-03-10","underlying":"Common Stock","underlying_shares":2700},"source":{"system":"sec-edgar","filing":"0000950170-24-000880","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017024000880/ownership.xml","form_type":"4"}},{"id":1692997,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-01-03T21:05:18.000Z","date":"2023-12-29","kind":"exercise","planned":false,"acquired":true,"shares":2700,"price":1.01,"value":2727.0,"ownership":{"direct":true},"balance_after":2700,"source":{"system":"sec-edgar","filing":"0000950170-24-000880","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017024000880/ownership.xml","form_type":"4"}},{"id":1727436,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-29T23:38:12.000Z","date":"2023-11-28","kind":"grant","planned":false,"acquired":true,"shares":230000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Corporation on each such vesting date."}],"balance_after":230000,"derivative":{"exercise_price":0.691,"expiration_date":"2033-11-27","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0001728117-23-000160","document":"wk-form4_1701301079.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586788/000172811723000160/wk-form4_1701301079.xml","form_type":"4"}},{"id":2072800,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-03T22:05:30.000Z","date":"2022-12-29","kind":"grant","acquired":true,"shares":132002,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in 48 equal monthly installments following December 29, 2022, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":132002,"derivative":{"exercise_price":13.5,"expiration_date":"2032-12-28","underlying":"Common Stock","underlying_shares":132002},"source":{"system":"sec-edgar","filing":"0000899243-23-000297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000089924323000297/doc4.xml","form_type":"4"}},{"id":3322373,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-01-03T21:45:09.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":4242,"price":52.52,"value":222789.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.12 to $52.84 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":53316,"source":{"system":"sec-edgar","filing":"0001179110-20-000274","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911020000274/edgar.xml","form_type":"4"}},{"id":3322372,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-01-03T21:45:09.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":1600,"price":52.51,"value":84016.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.12 to $52.83 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":57558,"source":{"system":"sec-edgar","filing":"0001179110-20-000274","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911020000274/edgar.xml","form_type":"4"}},{"id":3418445,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-09-10T20:23:46.000Z","date":"2019-09-10","kind":"sale","acquired":false,"shares":3584,"price":45.23,"value":162104.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.86 to $45.65 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":59158,"source":{"system":"sec-edgar","filing":"0001179110-19-010221","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911019010221/edgar.xml","form_type":"4"}},{"id":3463484,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2019-07-11T16:26:28.000Z","date":"2019-07-09","kind":"exercise","acquired":false,"shares":1562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this option award vested in equal quarterly installments over the first four years after the grant."}],"balance_after":0,"derivative":{"exercise_price":7.12,"expiration_date":"2022-12-12","underlying":"Common Stock","underlying_shares":1562},"source":{"system":"sec-edgar","filing":"0001179110-19-008579","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911019008579/edgar.xml","form_type":"4"}},{"id":3463483,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2019-07-11T16:26:28.000Z","date":"2019-07-09","kind":"exercise","acquired":false,"shares":2346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this option award vested in equal quarterly installments over the first four years after the grant."}],"balance_after":0,"derivative":{"exercise_price":5.28,"expiration_date":"2021-12-16","underlying":"Common Stock","underlying_shares":2346},"source":{"system":"sec-edgar","filing":"0001179110-19-008579","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911019008579/edgar.xml","form_type":"4"}},{"id":3463482,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2019-07-11T16:26:28.000Z","date":"2019-07-09","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this option award vested in equal quarterly installments over the first four years after the grant."}],"balance_after":0,"derivative":{"exercise_price":3.88,"expiration_date":"2020-12-02","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001179110-19-008579","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911019008579/edgar.xml","form_type":"4"}},{"id":3463481,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-07-11T16:26:28.000Z","date":"2019-07-09","kind":"exercise","acquired":true,"shares":1562,"price":7.12,"value":11121.44,"ownership":{"direct":true},"balance_after":62742,"source":{"system":"sec-edgar","filing":"0001179110-19-008579","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911019008579/edgar.xml","form_type":"4"}},{"id":3463480,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-07-11T16:26:28.000Z","date":"2019-07-09","kind":"exercise","acquired":true,"shares":2346,"price":5.28,"value":12386.88,"ownership":{"direct":true},"balance_after":61180,"source":{"system":"sec-edgar","filing":"0001179110-19-008579","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911019008579/edgar.xml","form_type":"4"}},{"id":3463479,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-07-11T16:26:28.000Z","date":"2019-07-09","kind":"exercise","acquired":true,"shares":5000,"price":3.88,"value":19400.0,"ownership":{"direct":true},"balance_after":58834,"source":{"system":"sec-edgar","filing":"0001179110-19-008579","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911019008579/edgar.xml","form_type":"4"}},{"id":3557396,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO and Secretary"}}],"security":"Common Stock","published_at":"2019-04-11T16:58:40.000Z","date":"2019-04-09","kind":"sale","acquired":false,"shares":70,"price":44.24,"value":3096.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":53834,"source":{"system":"sec-edgar","filing":"0001179110-19-004912","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911019004912/edgar.xml","form_type":"4"}},{"id":3557395,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO and Secretary"}}],"security":"Common Stock","published_at":"2019-04-11T16:58:40.000Z","date":"2019-04-09","kind":"sale","acquired":false,"shares":100,"price":45.46,"value":4546.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":53904,"source":{"system":"sec-edgar","filing":"0001179110-19-004912","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911019004912/edgar.xml","form_type":"4"}},{"id":3557394,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO and Secretary"}}],"security":"Common Stock","published_at":"2019-04-11T16:58:40.000Z","date":"2019-04-09","kind":"sale","acquired":false,"shares":3452,"price":44.62,"value":154028.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.31 to $45.05 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":54004,"source":{"system":"sec-edgar","filing":"0001179110-19-004912","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911019004912/edgar.xml","form_type":"4"}},{"id":3683696,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO and Secretary"}}],"security":"Option to Purchase Common Stock","published_at":"2019-01-29T17:41:07.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award vest in equal quarterly installments over the four years after January 1, 2019."}],"balance_after":28500,"derivative":{"exercise_price":41.64,"expiration_date":"2029-01-25","underlying":"Common Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0001179110-19-001055","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911019001055/edgar.xml","form_type":"4"}},{"id":3683695,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO and Secretary"}}],"security":"Common Stock","published_at":"2019-01-29T17:41:07.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":4800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":57456,"source":{"system":"sec-edgar","filing":"0001179110-19-001055","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911019001055/edgar.xml","form_type":"4"}},{"id":3703621,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO and Secretary"}}],"security":"Common Stock","published_at":"2019-01-04T18:35:40.000Z","date":"2019-01-02","kind":"sale","acquired":false,"shares":475,"price":43.92,"value":20862.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.87 to $44.08 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (6) to this Form 4."}],"balance_after":52656,"source":{"system":"sec-edgar","filing":"0001179110-19-000469","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911019000469/edgar.xml","form_type":"4"}},{"id":3703620,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO and Secretary"}}],"security":"Common Stock","published_at":"2019-01-04T18:35:40.000Z","date":"2019-01-02","kind":"sale","acquired":false,"shares":2558,"price":43.1,"value":110249.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.78 to $43.66 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5) to this Form 4."}],"balance_after":53131,"source":{"system":"sec-edgar","filing":"0001179110-19-000469","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911019000469/edgar.xml","form_type":"4"}},{"id":3703619,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO and Secretary"}}],"security":"Common Stock","published_at":"2019-01-04T18:35:40.000Z","date":"2019-01-02","kind":"sale","acquired":false,"shares":1300,"price":42.31,"value":55003.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.78 to $42.74 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4."}],"balance_after":55689,"source":{"system":"sec-edgar","filing":"0001179110-19-000469","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911019000469/edgar.xml","form_type":"4"}},{"id":3703618,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO and Secretary"}}],"security":"Common Stock","published_at":"2019-01-04T18:35:40.000Z","date":"2019-01-02","kind":"sale","acquired":false,"shares":300,"price":43.26,"value":12978.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.15 to $43.47 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":56989,"source":{"system":"sec-edgar","filing":"0001179110-19-000469","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911019000469/edgar.xml","form_type":"4"}},{"id":3703617,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO and Secretary"}}],"security":"Common Stock","published_at":"2019-01-04T18:35:40.000Z","date":"2019-01-02","kind":"sale","acquired":false,"shares":1309,"price":42.32,"value":55396.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.77 to $42.76 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":57289,"source":{"system":"sec-edgar","filing":"0001179110-19-000469","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911019000469/edgar.xml","form_type":"4"}},{"id":3936797,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO and Secretary"}}],"security":"Option to Purchase Common Stock","published_at":"2018-05-11T16:59:39.000Z","date":"2018-05-10","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options of registrant's common stock vest in equal quarterly installments over the first four years after the grant."}],"balance_after":10000,"derivative":{"exercise_price":34.94,"expiration_date":"2028-05-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-18-006662","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911018006662/edgar.xml","form_type":"4"}},{"id":3936796,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO and Secretary"}}],"security":"Common Stock","published_at":"2018-05-11T16:59:39.000Z","date":"2018-05-10","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":58598,"source":{"system":"sec-edgar","filing":"0001179110-18-006662","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911018006662/edgar.xml","form_type":"4"}},{"id":3969567,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Dev., GC & Sec."}}],"security":"Common Stock","published_at":"2018-04-04T16:40:15.000Z","date":"2018-04-03","kind":"sale","acquired":false,"shares":100,"price":39.16,"value":3916.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":56598,"source":{"system":"sec-edgar","filing":"0001179110-18-005398","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911018005398/edgar.xml","form_type":"4"}},{"id":3969566,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Dev., GC & Sec."}}],"security":"Common Stock","published_at":"2018-04-04T16:40:15.000Z","date":"2018-04-03","kind":"sale","acquired":false,"shares":1104,"price":38.33,"value":42316.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.90 to $38.89 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":56698,"source":{"system":"sec-edgar","filing":"0001179110-18-005398","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911018005398/edgar.xml","form_type":"4"}},{"id":4014531,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Dev., GC & Sec."}}],"security":"Option to Purchase Common Stock","published_at":"2018-03-05T17:14:51.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":28950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award vest in equal quarterly installments over the four years after January 1, 2018."}],"balance_after":28950,"derivative":{"exercise_price":40.61,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":28950},"source":{"system":"sec-edgar","filing":"0001179110-18-003495","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911018003495/edgar.xml","form_type":"4"}},{"id":4014530,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Dev., GC & Sec."}}],"security":"Common Stock","published_at":"2018-03-05T17:14:51.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":4825,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":57802,"source":{"system":"sec-edgar","filing":"0001179110-18-003495","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911018003495/edgar.xml","form_type":"4"}},{"id":4107213,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Dev., GC & Sec."}}],"security":"Common Stock","published_at":"2018-01-04T19:03:43.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":4333,"price":42.42,"value":183805.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.95 to $42.88 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":52977,"source":{"system":"sec-edgar","filing":"0001179110-18-000547","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911018000547/edgar.xml","form_type":"4"}},{"id":4209257,"issuer":{"id":15780,"kind":"organization","name":"ACCELERON PHARMA INC","symbol":"XLRN"},"owners":[{"id":22283,"kind":"person","name":"Quisel John D","position":1,"cik":"0001586788","reported_name":"Quisel John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Dev., GC & Sec."}}],"security":"Common Stock","published_at":"2017-09-14T17:03:19.000Z","date":"2017-09-13","kind":"sale","acquired":false,"shares":8,"price":38.03,"value":304.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":57310,"source":{"system":"sec-edgar","filing":"0001179110-17-012289","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1280600/000117911017012289/edgar.xml","form_type":"4"}}],"next_cursor":"2017-09-14T17:03:19.000000Z,4209257"}